A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 297,576 shares of AZN stock, worth $19.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
297,576
Previous 179,217 66.04%
Holding current value
$19.3 Million
Previous $14 Million 65.89%
% of portfolio
0.1%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$76.67 - $87.62 $9.07 Million - $10.4 Million
118,359 Added 66.04%
297,576 $23.2 Million
Q2 2024

Jul 30, 2024

SELL
$66.81 - $80.83 $30.2 Million - $36.5 Million
-452,105 Reduced 71.61%
179,217 $14 Million
Q1 2024

May 01, 2024

BUY
$61.03 - $69.57 $1.53 Million - $1.75 Million
25,150 Added 4.15%
631,322 $42.8 Million
Q4 2023

Jan 24, 2024

SELL
$61.89 - $69.28 $523,156 - $585,623
-8,453 Reduced 1.38%
606,172 $40.8 Million
Q3 2023

Oct 26, 2023

BUY
$64.85 - $71.7 $5.75 Million - $6.36 Million
88,638 Added 16.85%
614,625 $41.6 Million
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $783,621 - $849,754
-11,209 Reduced 2.09%
525,987 $37.6 Million
Q1 2023

May 04, 2023

SELL
$63.15 - $71.6 $815,392 - $924,499
-12,912 Reduced 2.35%
537,196 $37.3 Million
Q4 2022

Feb 09, 2023

SELL
$54.21 - $70.44 $584,600 - $759,624
-10,784 Reduced 1.92%
550,108 $37.3 Million
Q3 2022

Nov 10, 2022

SELL
$53.02 - $135.75 $701,931 - $1.8 Million
-13,239 Reduced 2.31%
560,892 $30.8 Million
Q2 2022

Jul 26, 2022

BUY
$59.26 - $71.14 $3.15 Million - $3.78 Million
53,156 Added 10.2%
574,131 $37.9 Million
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $22.1 Million - $26.6 Million
396,202 Added 317.54%
520,975 $34.6 Million
Q4 2021

Feb 08, 2022

BUY
$54.02 - $63.83 $1.5 Million - $1.78 Million
27,814 Added 28.69%
124,773 $7.27 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $172,569 - $188,813
3,106 Added 3.31%
96,959 $5.82 Million
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $1.2 Million - $1.49 Million
24,747 Added 35.81%
93,853 $5.62 Million
Q1 2021

May 13, 2021

SELL
$47.16 - $54.44 $658,872 - $760,581
-13,971 Reduced 16.82%
69,106 $3.44 Million
Q4 2020

Feb 10, 2021

BUY
$48.52 - $58.02 $386,510 - $462,187
7,966 Added 10.61%
83,077 $4.15 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $474,711 - $546,539
-8,945 Reduced 10.64%
75,111 $4.12 Million
Q2 2020

Aug 11, 2020

SELL
$43.1 - $55.31 $328,809 - $421,959
-7,629 Reduced 8.32%
84,056 $4.45 Million
Q1 2020

May 12, 2020

BUY
$37.79 - $51.33 $1.67 Million - $2.27 Million
44,203 Added 93.09%
91,685 $4.1 Million
Q4 2019

Feb 12, 2020

BUY
$42.46 - $50.46 $218,626 - $259,818
5,149 Added 12.16%
47,482 $2.37 Million
Q3 2019

Nov 12, 2019

SELL
$40.12 - $45.47 $54,081 - $61,293
-1,348 Reduced 3.09%
42,333 $1.89 Million
Q2 2019

Aug 13, 2019

SELL
$37.28 - $41.68 $1.73 Million - $1.94 Million
-46,533 Reduced 51.58%
43,681 $1.8 Million
Q1 2019

May 13, 2019

SELL
$35.49 - $43.02 $1.45 Million - $1.75 Million
-40,724 Reduced 31.1%
90,214 $3.65 Million
Q4 2018

Feb 11, 2019

SELL
$36.86 - $41.49 $1.53 Million - $1.72 Million
-41,404 Reduced 24.02%
130,938 $4.97 Million
Q3 2018

Nov 13, 2018

SELL
$34.76 - $39.72 $233,343 - $266,640
-6,713 Reduced 3.75%
172,342 $6.82 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $2.89 Million - $3.1 Million
-83,719 Reduced 31.86%
179,055 $6.29 Million
Q1 2018

May 10, 2018

BUY
$32.97 - $36.63 $1.2 Million - $1.34 Million
36,517 Added 16.14%
262,774 $9.19 Million
Q4 2017

Feb 12, 2018

BUY
$32.09 - $34.78 $153,454 - $166,317
4,782 Added 2.16%
226,257 $7.85 Million
Q3 2017

Nov 08, 2017

SELL
$28.96 - $34.0 $240,657 - $282,540
-8,310 Reduced 3.62%
221,475 $7.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
229,785
229,785 $7.83 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.